 "Pfizer Q2 profit dips 13.81% to Rs 958 million, revenue drops marginally")
Drug firm Pfizer on Wednesday reported a 13.81 per cent dip in standalone net profit to Rs 958 million for the quarter ended September 2018.
The company had posted a net profit of Rs 1.11 billion for the corresponding period of the previous financial year.
Revenue from operations of the company stood at Rs 5.19 billion in the quarter under review. It was Rs 5.71 billion in the September quarter a year ago, Pfizer said in a filing to BSE.
Shares of Pfizer were trading at Rs 2,808 apiece in afternoon trade on BSE, down 1.87 per cent from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app